Table 6 Expression of CD8+ T cells and tumor mutation burden.
From: PD-L1 expression and its correlation with tumor biomarkers in Chinese urothelial bladder cancer
Variable | Total (n = 229) |
|---|---|
Percentage of CD8+ T cells, % | |
Mean (SD) | 6.1 (8.8) |
Median (Q1, Q3) | 3.0 (1.0, 7.0) |
Percentage of CD8+ T cells category, n (%) | |
CD8+ High (> median value 3.0%) | 102 (44.5) |
CD8+ Low (≤ median value 3.0%) | 126 (55.0) |
Missing | 1 (0.4) |
TMB, Mut/Mb | |
Mean (SD) | 14.1 (11.1) |
Median (Q1, Q3) | 11.0 (7.2, 17.6) |
TMB category, n (%) | |
TMB high (> 10 mut/Mb) | 124 (54.1) |
Non- TMB high (≤ 10 mut/Mb) | 92 (40.2) |
Missing | 13 (5.7) |
